To improve medication reconciliation in oncologic patients in healthcare transitions through an alliance between a Cancer Institute and the community pharmacies and a new integrated IT platform.
This trial will explore the alliance between a Cancer Institute and the community pharmacies to improve medication reconciliation in healthcare transitions, and will validate a new integrated IT platform. Cancer patients receiving an oncologic treatment will be asked to choose a pharmacy participating to the trial, and to perform the pharmacological survey before every cycle of chemotherapy. This will be sent through the new IT platform to the electronic medical record of IRST, and the Oncologist will perform the reconciliation. Data about concomitant medications and possible interactions will be exensively analyzed.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
100
medication reconciliation
Alessandro Passardi
Meldola, FC, Italy
medication recognition and reconciliation maintenance
number of reconciliations per patient
Time frame: At day 1 of each cycle of treatment (each cycle might be 14, 21 or 28 days)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.